Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY

Benzinga Newsdesk www.benzinga.com Positive 59.6%

Neg 0% Neu 0% Pos 59.6%

Scinai Immunotherapeutics (NASDAQ:SCNI) reported quarterly losses of $(3.56) per share. The company reported $1.311 million in sales this quarter. This is a 99.24 percent increase over sales of $658.000 thousand the same period last year.